Relying on the one-stop supply chain system of MineBio’s parent company LabDirect China Limited and the advantages of import and export of high-risk biological products, MineBio provides quality solutions from R&D to clinical and commercial production of biological products in the field of cell gene therapy/stem cell/regenerative medicine and antibody-protein drugs, those are including:
1) research-grade to clinical-grade/cGMP animal-free culture matrix/transfection reagents/viral transduction
2) library customization and licensing of flexible CHO-engineered cell lines for protein, enzyme and antibody drugs;
3) 3D culture and organ-on-a-chip technology for organoid and regenerative medicine to support translational medicine research.
Company Details
- Employees
- 13
- Founded
- 2019
- Address
- Zhangjiang High-Tech Park, Shanghai,china
- Industry
- Wholesale Drugs And Sundries
- NAICS
-
Drugs and Druggists' Sundries Merchant Wholesalers
- Website
- https://www.mine-bio.com/
- HQ
- Shanghai
Minebio Life Sciences Limited Questions
Minebio Life Sciences Limited's website is https://www.mine-bio.com/
Minebio Life Sciences Limited's LinkedIn profile is https://cn.linkedin.com/company/minebio-life-sciences-limited
Minebio Life Sciences Limited has
13 employees.
View email and phone details for 13
employees at Minebio Life Sciences Limited.
Minebio Life Sciences Limited's industry is
Wholesale Drugs and Sundries
Minebio Life Sciences Limited's top competitors are
Akita, By Finnadvance,
Medicilon Inc.,
Axol Bioscience Ltd.,
Sexton Biotechnologies,
Femtobiomed Inc.,
Pear Bio,
Cn Bio,
Ice Bioscience,
Packgene Biotech, Inc.,
Atelerix Ltd..
Minebio Life Sciences Limited's categories are Wholesale Drugs and Sundries
Minebio Life Sciences Limited's founding year is 2019
